GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Psycheceutical Bioscience BWVI · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 27 Oct 2026, in USD

Psycheceutical Bioscience annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In USD.

FY2022FY2021FY2020FY2019FY2017
Revenue——$83,779$104,271$75,687
Operating income−$11.4m−$1.4m−$135,100−$498,880−$426,770
Net income−$17.0m−$1.4m−$113,620−$529,427−$581,731
Free cash flow−$3.5m−$869,710−$34,460−$403,960−$285,901
Total assets$2.3m$327,323$1.2m$1.2m$194,028
Shareholders' equity−$135,097$62,943−$1.0m−$919,975−$2.6m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.